Are we contented with achieving universal health coverage in treating dengue patients in Sri Lanka?

Authors

  • Nadeeka D. Perera Ministry of Health, Colombo, Sri Lanka http://orcid.org/0000-0003-2725-3086
  • Shamini Prathapan Department of Community Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
  • Amala De Silva Department of Economics, University of Colombo, Colombo, Sri Lanka
  • Dulshika A. Wass Department of Psychiatry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka
  • Ananda Wijewickrama National Institute of Infectious Diseases (IDH), Angoda, Sri Lanka

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20223199

Keywords:

Dengue infection, Household cost, OOPE

Abstract

Background: The preventive and curative services for dengue illness cause a significant financial burden on the state health sector. Household costs and out-of-pocket expenditure (OOPE) too are important cost components embedded with dengue illness. The objective was to estimate the household costs and out-of-pocket expenses incurred due to dengue infection among adults who received institutional care in Colombo district, Sri Lanka.

Methods: A longitudinal study was conducted from July to December 2018. Fifty patients recruited from dengue fever (DF) and dengue hemorrhagic fever (DHF) categories. Adults residing in the Colombo district for more than six months prior to dengue illness were recruited based on systematic sampling. Data was collected via an interviewer-administered questionnaire on the day of discharge from the hospital and followed up for two weeks. Unit cost per patient was calculated. Household costs were calculated for 3 phases: ambulatory, during, and post-hospitalization. These components were described using mean, median, standard deviation and inter-quartile range, and OOPE.

Results: The median age in the DF group was 38.5 years and in the DHF group was 28.5 years. The average household cost was US$ 127.69 (SD=93.32) and US$ 134.71 (SD=94.31) for DF and DHF patients respectively. Among DF patients 98.03% were borne using OOPE and among DHF patients it was 95.57%.

Conclusions: If an adult member is hospitalized with dengue infection the OOPE is high, which is nearly 25% of a family’s monthly income. Strengthening dengue control programme is the key to universal health coverage (UHC). 

Author Biographies

Nadeeka D. Perera, Ministry of Health, Colombo, Sri Lanka

Acting Consultant Community Physician

Shamini Prathapan, Department of Community Medicine, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka

Professor in Community Medicine

Amala De Silva, Department of Economics, University of Colombo, Colombo, Sri Lanka

Professor in Economics

Dulshika A. Wass, Department of Psychiatry, Faculty of Medical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka

Senior Lecturer in Psychiatry

Ananda Wijewickrama, National Institute of Infectious Diseases (IDH), Angoda, Sri Lanka

Consultant Physician

References

Shepard DS, Undurraga EA, Lees RS, Halasa Y, Lum LC, Ng CW. Use of multiple data sources to estimate the economic cost of dengue illness in Malaysia. Am J Trop Med Hygiene. 2012;87(5):796-805.

Simmons PC, Farrar JJ, Chau NV, Wills B. Dengue: Review Article. N Eng J Med. 2012;366(15):1423-32.

World Health Organization. Dengue Fact Sheet. Regional Office of South East Asia: Geneva: World Health Organization. 2012. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed on 26 Oct, 2022.

Ministry of Health. Epidemiology of Dengue, National Dengue Control Unit, Ministry of Health, Sri Lanka. 2019.

Ministry of Health. Annual Health Bulletin, Ministry of Health, Sri Lanka. 2015.

Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. PLoS Neglected Trop Dis. 2013;7(2).

Senanayake M, Jayasinghe S, Wijesundera D, Manamperi M. Economic cost of hospitalized non-fatal paediatric dengue at the Lady Ridgeway Hospital for Children in Sri Lanka. Sri Lanka J Child Heal. 2014;12:43(4).

Thalagala N, Tissera H, Palihawadana P, Amarasinghe A, Ambagahawita A, Wilder-Smith A et al. Costs of dengue control activities and hospitalizations in the public health sector during an epidemic year in urban Sri Lanka. PLoS Neglected Trop Dis. 2016;10(2).

Zaleski ID. Why cost-of-illness studies are important and inform policy. Vascular Med. 2008;13:251-3.

De Silva A. Review of Costing Studies Conducted in Sri Lanka, 1990-2004. National Commission on Macroeconomics and Health, Ministry of Healthcare and Nutrition. 2007.

Armien B, Arredondo J, Carabali M, Carrasquilla G, Castro R, Durand L et al. Costing dengue cases and outbreaks: A guide to current practices and procedures. Pan American Health and Education Foundation, International Vaccine Access Center, and Dengue Vaccine Initiative, Baltimore, MD. 2012.

Kasturiratne KTAA, Morbidity pattern and economic burden of non-communicable diseases at Tertiary care level. Theses: Post Graduate Institute of Medicine, University of Colombo, Sri Lanka. 2003.

Downloads

Published

2022-11-28

How to Cite

Perera, N. D., Prathapan, S., Silva, A. D., Wass, D. A., & Wijewickrama, A. (2022). Are we contented with achieving universal health coverage in treating dengue patients in Sri Lanka?. International Journal Of Community Medicine And Public Health, 9(12), 4334–4340. https://doi.org/10.18203/2394-6040.ijcmph20223199

Issue

Section

Original Research Articles